Treatment with denosumab may increase bone mineral density in older women with primary hyperparathyroidism-related osteoporosis.
Seventy-five randomized controlled trials were included in a meta-analysis comparing DDP-4 inhibitors with placebo and other diabetes medications.
Routine vitamin D and calcium supplementation in older adults is not supported for lowering the incidence of osteoporosis-related fractures.
Among older adults with functional limitations, a long-term physical activity program was not associated with reduced frailty risk.
Lower rates for hip fractures in women are linked to high intake of fermented milk products, along with fruits and vegetables.
The risk for venous thromboembolism among strontium ranelate, denosumab, teriparatide, alendronate, and other bisphosphonates was evaluated by investigators.
Hip fracture repair was linked to higher rates of 30-day mortality and post-operative complications when time between hospital arrival and surgery exceeded 24 hours.
Tocilizumab treatment for 2 years was shown to reduce levels of bone loss in patients with ACPA-positive RA.
In patients with hip fractures, the use of a regional nerve block may provide pain relief, and decrease the risk for pneumonia.
Caffeine intake among women older than 50 may have a small association with a decrease in BMD, and may increase risk of hip fractures.
Rapid loss of bone density is linked with the use of insulin for T2D.
This suggests to us that, as is the standard now, when we use an anabolic agent, we can add in an antiresorptive such as alendronate, and see continued sustained reduction in fracture risk.
Growth hormone therapy may reduce the risk for fracture in patients with osteoporosis.
Greater visceral and/or subcutaneous adiposity may have an important role in bone growth during adolescence.
Investigators evaluated the efficacy of teriparatide vs risedronate in preventing clinical and vertebral fracture in post-menopausal women with existing vertebral fractures.
All women 65, high-risk postmenopausal women 65 should undergo bone measurement testing.
In postmenopausal women at high risk for fracture, treatment with romosozumab for 12 months, followed by alendronate, was associated with significantly fewer hip fractures than treatment with alendronate alone.
Higher dietary fiber and fruit fiber is protective against bone loss at the femoral neck in men.
The use of vertebral fracture assessment has shown adequate performance for the detection of vertebral fractures.
Prolonged antiresorptive activity of ≥3 years has been associated with single zoledronate doses between 1 and 5 mg in postmenopausal women with osteopenia.
Tymlos is approved to treat postmenopausal women with osteoporosis at high risk for fracture.
Clinically undiagnossed radiographic VFs are linked to increased back pain symptoms.
Quality of life is similarly impacted by osteoporotic fractures and complications of diabetes.
The risk of bone health decline in menopausal women is decreased by intermittent hypoxia in OSA.
Risk of bone health decline in menopausal women is decreased by intermittent hypoxia in OSA.
Anxiety and depression are associated with low BMD in anorexia patients.
In people with class III obesity, variance in femoral neck BMD can be determined by time spent doing light physical activity.
Following adjustment, fracture risk was highest among patients in the lowest osteoprotegerin levels.
To improve pain relief, surgeons should proactively address stress, distress, and ineffective coping strategies.
K-Postn may serve as a predictor of incident low-trauma fractures in postmenopausal women.
Rheumatology Advisor Articles
- Raynaud Phenomenon, Migraine Linked to aPS/PT Antibodies in Primary Antiphospholipid Syndrome
- Case Study: A Syncopal Episode During a Camping Trip
- Then and Now: The Crisis of Physician Suicides
- Increased HLA-B27 Associated With More Severe Sonographic Enthesitis in PsA
- Aspirin Similar to Rivaroxaban for VTE Prophylaxis After Hip, Knee Arthroplasty
- FDA Advises Recall: Limbrel May Be Linked to Drug-Induced Liver Injury
- Allopurinol Use May Lower Risk for Peripheral Arterial Disease
- Managing Treatment Nonadherence in Rheumatic Diseases
- Optimal Fibromyalgia Management Includes Individualized, Multimodal Therapy
- Risk for COPD, Asthma Among Women With Rheumatoid Arthritis: Nurses' Health Study
- Ocular Complications of Gout: The Spectrum of Urate Crystal Deposition
- Digital Medicine Innovations Expand Access to Rural, Low-Income Communities
- Elevated Serum Uric Acid Levels May Increase Risk for Dementia in Older Adults
- Implications of the Regulatory Accountability Act on Public Health
- Synovial Joint Biopsy Techniques: Arthroscopy vs Ultrasound-Guided Methods